Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trialDerin B. Keskin, David A. Reardon|Nature|2018Cited by 1.4k
A large peptidome dataset improves HLA class I epitope prediction across most of the human populationSiranush Sarkizova, Derin B. Keskin, Thomas Eisenhaure et al.|Nature Biotechnology|2019Cited by 539
Progressive immune dysfunction with advancing disease stage in renal cell carcinomaDavid A. Braun, Catherine J. Wu, Kelly Street et al.|Cancer Cell|2021Cited by 515
Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid MalignanciesRomain Guièze, Catherine J. Wu, Vivian M. Liu et al.|Cancer Cell|2019Cited by 361
Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapySatyen H. Gohil, Kenneth J. Livak, J. Bryan Iorgulescu et al.|Nature Reviews Clinical Oncology|2020Cited by 286